Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.
复制标题
DOI:
10.1016/j.cancergen.2015.01.007
复制
发表时间:
2015-04
期刊:
影响因子:
1.9
通讯作者:
Bessler M
中科院分区:
文献类型:
--
作者:
Babushok DV;Perdigones N;Perin JC;Olson TS;Ye W;Roth JJ;Lind C;Cattier C;Li Y;Hartung H;Paessler ME;Frank DM;Xie HM;Cross S;Cockroft JD;Podsakoff GM;Monos D;Biegel JA;Mason PJ;Bessler M
Acquired aplastic anemia (aAA) is a non-malignant disease caused by autoimmune destruction of early hematopoietic cells. Clonal hematopoiesis is a late complication, seen in 20–25% of older patients. We hypothesized that clonal hematopoiesis in aAA is a more general phenomenon, which can arise early in disease even in younger patients. To evaluate clonal hematopoiesis in aAA, we used comparative whole exome sequencing of paired bone marrow and skin in 22 patients. We found somatic mutations in sixteen patients (72.7%) with a median disease duration of 1 year; twelve (66.7%) were patients with pediatriconset aAA. Fifty-eight mutations in 51 unique genes were primarily in pathways of immunity and transcriptional regulation. Most frequently mutated was PIGA, with 7 mutations. Only two mutations were in genes recurrently-mutated in MDS. Two patients had oligoclonal loss of HLA alleles, linking immune escape to clone emergence. Two patients had activating mutations in key signaling pathways (STAT5B(p.N642H), CAMK2G(p.T306M)). Our results suggest that clonal hematopoiesis in aAA is common, with two mechanisms emerging― immune escape and increased proliferation. Our findings expand conceptual understanding of this non-neoplastic blood disorder. Future prospective studies of clonal hematopoiesis in aAA will be critical for understanding outcomes, and for designing personalized treatment strategies.
登录
查看更多内容
影响因子:
30.8
作者:
Busque L;Patel JP;Figueroa ME;Vasanthakumar A;Provost S;Hamilou Z;Mollica L;Li J;Viale A;Heguy A;Hassimi M;Socci N;Bhatt PK;Gonen M;Mason CE;Melnick A;Godley LA;Brennan CW;Abdel-Wahab O;Levine RL
通讯作者:
Levine RL
DOI:
10.1056/nejmoa1409405
发表时间:
2014-12-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Genovese G;Kähler AK;Handsaker RE;Lindberg J;Rose SA;Bakhoum SF;Chambert K;Mick E;Neale BM;Fromer M;Purcell SM;Svantesson O;Landén M;Höglund M;Lehmann S;Gabriel SB;Moran JL;Lander ES;Sullivan PF;Sklar P;Grönberg H;Hultman CM;McCarroll SA
通讯作者:
McCarroll SA
影响因子:
--
作者:
Kubokawa M;Nakamura K;Komagiri Y
通讯作者:
Komagiri Y
影响因子:
7.8
作者:
Du, Hong-Yan;Idol, Rachel;Bessler, Monica
通讯作者:
Bessler, Monica
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y